MDK-6983

CAS No. 1227476-98-3

MDK-6983( Autophagy inhibitor 6k | Compound 6k | MDK-6983 | MDK 6983 | MDK6983 )

Catalog No. M27899 CAS No. 1227476-98-3

MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 283 In Stock
5MG 249 In Stock
10MG 368 In Stock
25MG 562 In Stock
50MG 770 In Stock
100MG 1032 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MDK-6983
  • Note
    Research use only, not for human use.
  • Brief Description
    MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
  • Description
    MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Autophagy inhibitor 6k | Compound 6k | MDK-6983 | MDK 6983 | MDK6983
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    microtubule
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1227476-98-3
  • Formula Weight
    429.3
  • Molecular Formula
    C22H18Cl2N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Oc1ccc(Cl)cc1C(=O)N[C@H](Cc1ccccc1)C(=O)Nc1ccc(Cl)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wood AC, et al. Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program. Pediatr Blood Cancer. 2013;60(11):1860-1867.
molnova catalog
related products
  • CP-312

    CP-312 (Cardioprotectant 312) is an antioxidant defense response activator that protects hiPSC-CM viability by acting through induction of heme oxygenase-1 and targeting the antioxidant response network by inducing HMOX1 expression.

  • Pitavastatin

    Pitavastatin (NK-104) is a potent inhibitor of hydroxymethylglutaryl-CoA (HMG-CoA) reductase, effectively inhibiting cholesterol synthesis from acetic acid in HepG2 cells with an IC50 of 5.8 nM.

  • Lys05

    Lys05 (Lys01 trihydrochloride, PS-1001)?is the water-soluble salt of Lys01, is a 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ); shows IC50 values of 3.6, 3.8, 6 and 7.9 uM for 1205Lu, c8161, LN229 and HT-29 cell line in the MTT assay.